Randomised controlled trial and economic evaluation of home-based medication and lifestyle review by community pharmacists for patients with heart failure
Completed
- Conditions
- Heart FailureCirculatory System
- Registration Number
- ISRCTN59427925
- Lead Sponsor
- niversity of East Anglia (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 306
Inclusion Criteria
1. Adult (over 18 years)
2. Discharged to home or warden controlled accommodation after an emergency admission in the last month with a primary clinical diagnosis of heart failure
3. Prescribed two or more drugs (oral or inhaled) taken on at least a daily basis
4. Norfolk or Suffolk resident
Exclusion Criteria
1. Patients living in residential, nursing homes or long-stay hospitals
2. All patients whose treatment includes planned surgery for ischaemic or valvular heart disease or awaiting heart transplantation
3. All patients with concomitant terminal malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total number of emergency hospital readmissions at six months
- Secondary Outcome Measures
Name Time Method 1. Total deaths at six months<br>2. Total heart failure hospital readmissions at six months<br>3. Self-assessed quality of life at six months using the EQ-5D and Minnesota living with heart failure questionnaire<br><br>Also: <br>1. Admissions to residential or nursing homes at six months <br>2. Self-assessed compliance at six months using the Medication Adherence Report scale<br>3. Self-assessed behaviour change at six months using the European heart failure self-care behaviour scale